173 related articles for article (PubMed ID: 7051971)
1. Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.
Gombert ME
Antimicrob Agents Chemother; 1982 Jun; 21(6):1011-2. PubMed ID: 7051971
[TBL] [Abstract][Full Text] [Related]
2. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.
Gombert ME; Aulicino TM
Antimicrob Agents Chemother; 1983 Nov; 24(5):810-1. PubMed ID: 6362558
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.
Gutmann L; Goldstein FW; Kitzis MD; Hautefort B; Darmon C; Acar JF
Antimicrob Agents Chemother; 1983 Feb; 23(2):248-51. PubMed ID: 6340602
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins.
Cynamon MH; Palmer GS
Antimicrob Agents Chemother; 1981 Dec; 20(6):841-2. PubMed ID: 7034644
[TBL] [Abstract][Full Text] [Related]
5. Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline.
Gombert ME; Aulicino TM; duBouchet L; Silverman GE; Sheinbaum WM
Antimicrob Agents Chemother; 1986 Aug; 30(2):270-3. PubMed ID: 3532945
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Nocardia asteroides to new quinolones and beta-lactams.
Gombert ME; Aulicino TM; duBouchet L; Berkowitz LR
Antimicrob Agents Chemother; 1987 Dec; 31(12):2013-4. PubMed ID: 3326528
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.
Gutiérrez Altés A; Díez Enciso M; Peña García P; Campos Bueno A
Antimicrob Agents Chemother; 1982 Mar; 21(3):501-3. PubMed ID: 6980624
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility profile of soil isolates of Nocardia asteroides from Kuwait.
Khan Z; Al-Sayer H; Chugh TD; Chandy R; Provost F; Boiron P
Clin Microbiol Infect; 2000 Feb; 6(2):94-8. PubMed ID: 11168079
[TBL] [Abstract][Full Text] [Related]
9. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
Liñares J; Perez JL; Garau J; Murgui L; Martín R
J Antimicrob Chemother; 1984 Apr; 13(4):353-9. PubMed ID: 6609919
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents.
Dewsnup DH; Wright DN
Antimicrob Agents Chemother; 1984 Feb; 25(2):165-7. PubMed ID: 6370125
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility patterns of Nocardia asteroides.
Wallace RJ; Steele LC; Sumter G; Smith JM
Antimicrob Agents Chemother; 1988 Dec; 32(12):1776-9. PubMed ID: 3072921
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole.
Bennett JE; Jennings AE
Antimicrob Agents Chemother; 1978 Apr; 13(4):624-7. PubMed ID: 352260
[TBL] [Abstract][Full Text] [Related]
13. Activity of antimicrobial drugs evaluated by agar dilution and radiometric methods against strains of Nocardia asteroides isolated in Italy from immunocompromised patients.
Scopetti F; Iona E; Fattorini L; Goglio A; Franceschini N; Amicosante G; Orefici G
J Chemother; 1994 Feb; 6(1):29-34. PubMed ID: 8071674
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
McNamara BT; Meyer RD; Pasiecznik KA
Antimicrob Agents Chemother; 1982 May; 21(5):753-7. PubMed ID: 6213196
[TBL] [Abstract][Full Text] [Related]
15. Synergistic action of trimethoprim and sulfamethoxazole for Nocardia asteroides: efficacious therapy in five patients.
Adams HG; Beeler BA; Wann LS; Chin CK; Brooks GF
Am J Med Sci; 1984; 287(1):8-12. PubMed ID: 6367470
[TBL] [Abstract][Full Text] [Related]
16. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Thompson RL; Fisher KA; Wenzel RP
Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].
Grimm H
Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
